Questions are being raised about not only the long term effectiveness of ADHD medications but on the integrity of researchers in providing information about the results. A large federal study has indicated that medication may not be effective after 24 months of use and that long-term use may indeed stunt growth in children.
The study followed three separate subgroups of children. One group, from social and economically stable homes showed little or no difference between children taking medica...
Read more »...diagnosis. Lawrence's behavior didn't exactly fit ADHD, and the doctor also is known for... Read more »
...medication for ADHD. These include the following: ADHD Medications have disturbing side... Read more »
...not at all. For these people, one of the other ADHD medications may work better. In... Read more »
My Attention Deficit Hyperactivity Disorder (ADHD) wasn't diagnosed till I was in my late thirties.... Read more »
...one doctor we could see in network tended to see ADHD everywhere. And sure enough, at the end of... Read more »
... (attention deficit hyperactivity disorder, or ADHD) as part of a total treatment plan... Read more »
... (attention deficit hyperactivity disorder, or ADHD) as part of a total treatment plan... Read more »
...treat attention deficit hyperactivity disorder (ADHD) as part of a total treatment plan,... Read more »
... (attention deficit hyperactivity disorder, or ADHD) as part of a total treatment plan... Read more »
...control attention deficit hyperactivity disorder (ADHD). It may help to increase the ability to... Read more »
Reports of sudden death, heart attacks, and strokes in users of ADHD medications has prompted the FDA to schedule a review of the drugs. Read summary »
A study of 15,690 people taking ADHD medications has found a difference in prescription rates between people who live in urban versus rural areas.... Read summary »
The U.S. Food and Drug Administration has approved a 30-minute onset of action for the ADHD drug Focalin XR. The new labeling is based on studies... Read summary »
Drugmaker Targacept Inc. says their experimental adult ADHD medication has met its primary target in a Phase II clinical trial. The... Read summary »
(Ivanhoe Newswire) -- Children with an undetected heart condition may be at risk of sudden cardiac death if they take stimulant medications. Now, new... Read summary »